NCT00253474View on ClinicalTrials.gov

PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

January 31, 2011

Conditions
Neoplasm of Uncertain Malignant PotentialUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

PEG-interferon alfa-2a

Trial Locations (4)

15213

Children's Hospital of Pittsburgh, Pittsburgh

60614

Children's Memorial Hospital - Chicago, Chicago

20010-2970

Children's National Medical Center, Washington D.C.

20892-1182

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT00253474 - PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma | Biotech Hunter | Biotech Hunter